Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06398457
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2024-05-01
Brief Title:
Darzalex Faspro Daratumumab and Hyaluronidase-fihj Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-08
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-02
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-01
First Submit QC Date:
May 2 2024
Study First Post Date:
2024-05-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-23
Last Update Post Date:
2024-07-11
Last Update Post Date Type:
ACTUAL